Adverse prognosis of bulky disease in good-risk DLBCL
- PMID: 18452849
- DOI: 10.1016/S1470-2045(08)70111-6
Adverse prognosis of bulky disease in good-risk DLBCL
Comment on
-
Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study.Lancet Oncol. 2008 May;9(5):435-44. doi: 10.1016/S1470-2045(08)70078-0. Epub 2008 Apr 8. Lancet Oncol. 2008. PMID: 18400558 Clinical Trial.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
